NPPB and hydrops fetalis: While the magnitude of the effects may vary, ARNI therapy generally leads to higher reductions in NT-proBNP levels—a marker of HF severity; it enhances hemodynamics, improves cardiac function by reducing afterload to a greater extent, increases natriuresis, and lowers systemic vascular resistance (SVR) more than those upon ACEI therapy.